Essex County — anchored by Newark — writes the heaviest surveys of New Jersey's three largest counties, at 4.77 deficiencies each. Yet it posts the lowest harm-level share (3.74%) and Immediate-Jeopardy rate (7.4%) of the three. Essex is the state's high-volume, lower-severity market, and its distinctive weakness is assessment accuracy.
The local fingerprint
Volume up, accuracy down
Essex leads with infection control (F880) and professional standards (F658), but its standout over-index is accuracy of assessments (F641) at 1.36× the state rate. When the MDS assessment is wrong, everything built on it — care plans, staffing, reimbursement — inherits the error. Essex's citation volume is high, but its jeopardy stays comparatively low, so the priority here is getting the paperwork right rather than bracing for catastrophe.
Prioritize assessment accuracy (F641): audit MDS coding against the clinical record before the survey window. Keep infection-control policies (F880) and professional-standards documentation (F658) current. With harm and jeopardy lower here, disciplined documentation is the highest-leverage investment.